Further, our studies revealed expression of XB130 in human thyroid tissue, and we found that XB130 is a downstream mediator of the signaling cascade propagated by RET/PTC, a genetically rearranged, constitutively active, thyroid cancer-specific tyrosine kinase [14]. The gene discussed is RET; the disease is thyroid cancer.